NCCN Guidelines® Insights: Squamous Cell Skin Cancer, Version 1.2022.
Publication
, Journal Article
Schmults, CD; Blitzblau, R; Aasi, SZ; Alam, M; Andersen, JS; Baumann, BC; Bordeaux, J; Chen, P-L; Chin, R; Contreras, CM; DiMaio, D; Farma, JM ...
Published in: J Natl Compr Canc Netw
December 2021
The NCCN Guidelines for Squamous Cell Skin Cancer provide recommendations for diagnostic workup, clinical stage, and treatment options for patients with cutaneous squamous cell carcinoma. The NCCN panel meets annually to discuss updates to the guidelines based on comments from panel members and the Institutional Review, as well as submissions from within NCCN and external organizations. These NCCN Guidelines Insights focus on the introduction of a new surgical recommendation terminology (peripheral and deep en face margin assessment), as well as recent updates on topical prophylaxis, immunotherapy for regional and metastatic disease, and radiation therapy.
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
J Natl Compr Canc Netw
DOI
EISSN
1540-1413
Publication Date
December 2021
Volume
19
Issue
12
Start / End Page
1382 / 1394
Location
United States
Related Subject Headings
- Skin Neoplasms
- Oncology & Carcinogenesis
- Immunotherapy
- Humans
- Epithelial Cells
- Carcinoma, Squamous Cell
- 4203 Health services and systems
- 3211 Oncology and carcinogenesis
Citation
APA
Chicago
ICMJE
MLA
NLM
Schmults, C. D., Blitzblau, R., Aasi, S. Z., Alam, M., Andersen, J. S., Baumann, B. C., … Nguyen, M. Q. (2021). NCCN Guidelines® Insights: Squamous Cell Skin Cancer, Version 1.2022. J Natl Compr Canc Netw, 19(12), 1382–1394. https://doi.org/10.6004/jnccn.2021.0059
Schmults, Chrysalyne D., Rachel Blitzblau, Sumaira Z. Aasi, Murad Alam, James S. Andersen, Brian C. Baumann, Jeremy Bordeaux, et al. “NCCN Guidelines® Insights: Squamous Cell Skin Cancer, Version 1.2022.” J Natl Compr Canc Netw 19, no. 12 (December 2021): 1382–94. https://doi.org/10.6004/jnccn.2021.0059.
Schmults CD, Blitzblau R, Aasi SZ, Alam M, Andersen JS, Baumann BC, et al. NCCN Guidelines® Insights: Squamous Cell Skin Cancer, Version 1.2022. J Natl Compr Canc Netw. 2021 Dec;19(12):1382–94.
Schmults, Chrysalyne D., et al. “NCCN Guidelines® Insights: Squamous Cell Skin Cancer, Version 1.2022.” J Natl Compr Canc Netw, vol. 19, no. 12, Dec. 2021, pp. 1382–94. Pubmed, doi:10.6004/jnccn.2021.0059.
Schmults CD, Blitzblau R, Aasi SZ, Alam M, Andersen JS, Baumann BC, Bordeaux J, Chen P-L, Chin R, Contreras CM, DiMaio D, Donigan JM, Farma JM, Ghosh K, Grekin RC, Harms K, Ho AL, Holder A, Lukens JN, Medina T, Nehal KS, Nghiem P, Park S, Patel T, Puzanov I, Scott J, Sekulic A, Shaha AR, Srivastava D, Stebbins W, Thomas V, Xu YG, McCullough B, Dwyer MA, Nguyen MQ. NCCN Guidelines® Insights: Squamous Cell Skin Cancer, Version 1.2022. J Natl Compr Canc Netw. 2021 Dec;19(12):1382–1394.
Published In
J Natl Compr Canc Netw
DOI
EISSN
1540-1413
Publication Date
December 2021
Volume
19
Issue
12
Start / End Page
1382 / 1394
Location
United States
Related Subject Headings
- Skin Neoplasms
- Oncology & Carcinogenesis
- Immunotherapy
- Humans
- Epithelial Cells
- Carcinoma, Squamous Cell
- 4203 Health services and systems
- 3211 Oncology and carcinogenesis